CVS Health Announces $260,000 in New Support for Bleeding Disorder Programs

The following is an excerpt from a press release from CVS. Read the entire press release here. 

Company to provide funding to National Hemophilia Foundation, Hemophilia Federation of America and local organizations across U.S.

CVS Health announced more than $260,000 in charitable commitments to local and national hemophilia and bleeding disorder programs across the country. The announcement of new commitments coincides with Bleeding Disorder Awareness Month, which is nationally recognized each year in March.
In the United States, more than 20,000 people are living with hemophilia, a condition in which blood does not clot properly in one’s body, causing pain and potential long-term consequences, and often requires whole blood or platelet transfusions.
“CVS Health recognizes the challenges that come with having a bleeding disorder, and the need for increased research and education,” said Joel Helle, Vice President, Specialty Sales, CVS Health. “By providing these leading organizations and programs with support, we’re able to help impact the care and quality of life for all people with a bleeding disorder, which advances our company’s purpose of helping people on their path to better health.”
To address this patient population, CVS Health is providing the Hemophilia Federation of America (HFA) with $50,000 to deliver increased education and support to bleeding disorder patients and their families, including HFA Families, which supports parents and children by providing educational tools and peer networks to better address the disorder, manage stress and equip families for success. The grant will also support Blood Brotherhood, which provides adult men who are living with blood disorders with support and education.
Read the rest of the press release here.